Subscribe to RSS
Spontaneous Remission of SSRI-induced Orgasm Delay
12 May 2004 (online)
Background: Orgasm delay is a common side effect of SSRIs, causing negative influence on patients’ compliance and quality of life. A possible strategy for the management of SSRI-induced orgasm delay is waiting for tolerance to develop. The authors studied the natural course of SSRI-induced orgasm delay over a period of 6 months.
Methods: One hundred eight patients having been started on SSRIs were included in an open, naturalistic study. Sexual dysfunction was assessed at monthly intervals using a structured interview.
Results: Twenty-six patients developed clinically relevant SSRI-induced orgasm delay. Eight patients (30.8 %) reported complete remission of sexual dysfunction, while four patients (15.4 %) noted a marked improvement. Four patients (15.4 %) continued to describe severe orgasm delay at the end of the observation period. High severity of orgasm delay significantly correlated with lack of remission.
Conclusions: A significant proportion of patients, especially those with mild to moderate orgasm delay, develop tolerance within 6 months.
- 1 Ashton A K, Rosen R C. Accommodation to SSRI-induced sexual dysfunction. J Sex Marital Ther. 1998; 24 191-192
- 2 Buchberger R, Wagner W. Fluvoxamine: Safety profile in extensive post-marketing surveillance. Pharmacopsychiatry. 2002; 35 101-108
- 3 Croft H, Settle E J r, Houser T, Batey S R, Donahue R M, Asher J A. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther. 1999; 21 643-658
- 4 Demyttenaere K, De Fruyt J, Sienaert P. Psychotropics and sexuality. Int Clin Psychopharmacol. 1998; 13 (suppl 6) 35-41
- 5 Herman J B, Brotman A W, Pollack M H, Falk W E, Biederman J, Rosenbaum J F. Fluoxetine-induced sexual dysfunction. J Clin Psychiatr. 1990; 51 25-27
- 6 Kavoussi R J, Segraves R T, Hughes A R, Asher J A, Johnston J A. Double blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatr. 1997; 58 532-7
- 7 Labbate L A, Grimes J B, Arana G W. Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders. Biol Psychiatr. 1998; 43 904-907
- 8 Lane R M. A critical review of selective serotonin inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management. J Psychopharmacol. 1997; 11(1) 72-82
- 9 Michael A, Andrews S. Paroxetine-induced vaginal anaesthesia. Pharmacopsychiatry. 2002; 35 101-108
- 10 Michelson D, Bancroft J, Targum S, Yongman K, Tepner R. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatr. 2000; 157 239-243
- 11 Moller H J, Berzewski H, Eckmann F, Ganzalves N, Kissling W, Knorr W, Ressler P. et al . Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients. Pharmacopsychiatry. 1993; 26 (3) 75-78
- 12 Montejo-Gonzales A L, Llorca G, Izquierdo J A, Ledesma A, Bousono M. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther. 1997; 23 176-194
- 13 Montejo-Gonzales A L, Llorca G, Izquierdo J A, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatr. 2001; 62 (suppl. 3) 10-21
- 14 Reimherr F W, Chouinard G, Cohn C K. et al . Antidepressant efficacy of sertraline: a double-blind, placebo- and amitryptiline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatr. 1990; 51 : 12 (suppl B) 18-27
- 15 Rosen R C, Lane R M, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999; 19 67-85
- 16 Shen W W, Sata L S. Inhibited female orgasm resulting from psychotropic drugs - a five year, updated, clinical review. J Reprod Med. 1990; 35 (1) 11-14
- 17 Waldinger M D, Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol. 1998; 13 (suppl. 6) 27-33
- 18 Zajecka J, Mitchell S, Fawcett J. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull. 1997; 33 (4) 755-760
- 19 Zajecka J. Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatr. 2001; 62 (suppl 3) 35-43
Dr. MD Egon Michael Haberfellner
Email: [email protected]